This one-day conference is designed to benefit functional/technical professionals working in the pharmaceutical and health care system dealing with the Pharmacovigilance system, such as: Pharmacovigilance dept.,Clinical operation dept.,Statistic dept.,Medical Affairs dept.,Regulatory Affairs dept. and Quality & Compliance dept.in pharmaceutical and Biotech companies, Clinical Research Organizations (CROs) and publich health centers.
For the third consecutive year, we will organise the French Pharmacovigilance Day to reflect on hot topics with PV specialists and explore what could be foreseen at Horizon 2020.
Patients’ involvement in Pharmacovigilance, impact of Brexit, signal detection and medication errors are some of the topics among others, currently under consideration by the organising committee. Interactions will provide attendees with regulatory references and best practices to meet regulator’s standards and expectations. Experience from last year meeting and attendees’ feedback will be taken into consideration to make of this third French Pharmacovigilance Day a successful and useful meeting.
The Scientific board:
Françoise de Crémiers, Founder and President at FdC Consulting
Solange Rohou, Senior Director at AstraZeneca
Evelyne Pierron, Consultant Pharmacovigilance Senior and Owner at Evelyne Pierron Consultants
will lead a panel of experts to share best practices, knowledge and experience in this field.
REGISTRATION FEE: 595,00 euro Early Bird fee until 3rd April 2017; 710,00 euro Ordinary fee (after 3rd April 2017); 590,00 euro Patronage members fee; 390,00 euro for Academy, Public Administration, Freelance. The fee includes: seat at the conference, copy of presentations of Speakers who allow the distribution, informative literature for the day, welcome coffee, networking lunch, coffee break, organisational office assistance, certificate of attendance.